21.00
-2.05%
Close of 9 Nov 2026, in NZD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About EBOS Group
Its shares trade on NZX under the ticker EBO.NZ. It has been listed since 16 June 1986. In the fiscal year to 30 June 2026, it reported revenue of A$10.38bn and net income of A$173.3m. At that date it held total assets of A$7.82bn and shareholders' equity of A$2.75bn.
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 16 Jun 1986
- Employees
- 3,300
- Website
- ebosgroup.com ↗
Leadership
Pay as last reported
- Ms. Elizabeth CouttsIndependent Non-Executive Chairman of the BoardNZD 408,450
- Mr. John Matthew CullityChief Executive OfficerA$6.6m
- Mr. Alistair GrayChief Financial Officer
- Mr. Brett BaronsChief Executive Officer - Symbion, since 2018
- Ms. Julie DillonChief Executive Officer - Animal Care
- Mr. Andrew McleanChief Executive Officer - Medical Technology
- Mr. Grant VineyChief Executive Officer of EBOS Animal Care
- Mr. Mithran NaikerChief Information Officer
- Ms. Janelle CainGeneral Counsel
- Ms. Jacinta McCarthyGroup General Manager - Human Resources
- Mr. Simon BundeExecutive General Manager Strategic Operations, ESG and Innovation, since 2022
- Mr. Martin KrauskopfExecutive General Manager - Strategy and Mergers and Acquisitions
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 68
- Environment
- 73
- Social
- 57
- Governance
- 73
- Direct emissions (scope 1)
- 3,530 t
- Energy emissions (scope 2)
- 18,289 t
- Women in the workforce
- 56%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- EBOS Group Ltd, a leading healthcare and animal care provider, holds several strengths that contribute to its success:
Weaknesses
- Despite its strengths, EBOS Group Ltd also faces certain weaknesses:
Opportunities
- EBOS Group Ltd can capitalize on the following opportunities in the market:
Threats
- However, EBOS Group Ltd also faces certain threats that could impact its performance:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.